TRIEU VUONG (CEO and Chairman of the Board) purchased 0.2% of their position (198.74K shares) of ONCOTELIC THERAPEUTICS, INC. on the open market
Open‑market purchase worth $993.68 — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 7/10/2025ACC: 0001641172-25-018620
DirectorOfficer10% Owner· CEO and Chairman of the Board
Since Apr 2019
+198.74K
Net shares
Net buyer
$993.68
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
198.74K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+94.74K
Price / share
$0.01
Trade value
$473.68
% of position
0.1%
7/8/2025
93.29M→93.39M
Common Stock
Direct
Shares
+1.00
Price / share
$0.01
Trade value
$0.01
% of position
0.0%
7/9/2025
93.29M→93.29M
Common Stock
Direct
Shares
+104K
Price / share
$0.01
Trade value
$520.00
% of position
0.1%
7/10/2025
93.19M→93.29M
Total
Net shares
+198.74K
Net value
$993.68
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/8/2025 | P · Purchase | +94.74K | $0.01 | $473.68 | 0.1% | 93.29M | 93.39M |
| Common Stock Direct | 7/9/2025 | P · Purchase | +1.00 | $0.01 | $0.01 | 0.0% | 93.29M | 93.29M |
| Common Stock Direct | 7/10/2025 | P · Purchase | +104K | $0.01 | $520.00 | 0.1% | 93.19M | 93.29M |
| Total | +198.74K | $993.68 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned6.87M
Common Stock
IndirectShares owned16.78M
Total
23.65M indirect23.65M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.87M | Indirect |
| Common Stock | 16.78M | Indirect |
| Total | 23.65M | 23.65M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported